0001493152-20-014591.txt : 20200804 0001493152-20-014591.hdr.sgml : 20200804 20200804160846 ACCESSION NUMBER: 0001493152-20-014591 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200804 DATE AS OF CHANGE: 20200804 EFFECTIVENESS DATE: 20200804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hancock Jaffe Laboratories, Inc. CENTRAL INDEX KEY: 0001661053 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330936180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-372469 FILM NUMBER: 201073368 BUSINESS ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-261-2900 MAIL ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 D 1 primary_doc.xml X0708 D LIVE 0001661053 Hancock Jaffe Laboratories, Inc. 70 DOPPLER IRVINE CA CALIFORNIA 92618 (949) 261-2900 DELAWARE None None Corporation true Robert Andrew Berman 70 Doppler Irvine CA CALIFORNIA 92618 Executive Officer Director CEO Craig Glynn 70 Doppler Irvine CA CALIFORNIA 92618 Executive Officer Interim CFO and Interim Treasurer Sanjay Shrivastava 70 Doppler Irvine CA CALIFORNIA 92618 Director Robert C. Gray 70 Doppler Irvine CA CALIFORNIA 92618 Director Francis Duhay 70 Doppler Irvine CA CALIFORNIA 92618 Director Matthew M. Jenusaitis 70 Doppler Irvine CA CALIFORNIA 92618 Director Mark H. Glickman 70 Doppler Irvine CA CALIFORNIA 92618 Executive Officer CVO and CMO Biotechnology Decline to Disclose 06b false 2020-07-21 false true true true false 100000 Ladenburg Thalmann & Co. Inc., 505 None None 999 VANDERBILT BEACH ROAD, SUITE 200 NAPLES, FL FLORIDA 34108 All States false 1556000 1556000 0 The Series C Convertible Preferred Stock and warrants were issued in a private placement that closed concurrently with an underwritten public offering, as disclosed on the issuer's Current Report on Form 8-K, filed with the SEC on July 21, 2020. false 4 102820 0 Placement agent fees. 0 false Hancock Jaffe Laboratories, Inc. /s/ Robert A. Berman Robert A. Berman Chief Executive Officer 2020-08-04